Drug Type Universal CAR-T |
Synonyms Universal GPC3-CAR-T cell(Wondercel Biotech), UWD-03 |
Target |
Action inhibitors |
Mechanism GPC3 inhibitors(Glypican-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Hepatocellular Carcinoma | Phase 1 | China | 23 Oct 2024 | |
| Advanced Lung Non-Small Cell Carcinoma | Phase 1 | China | 23 Oct 2024 | |
| squamous cell lung carcinoma | Clinical | China | 01 Sep 2026 |





